441 related articles for article (PubMed ID: 15548559)
1. Pathological study of spinal cord atrophy in multiple sclerosis suggests limited role of local lesions.
Evangelou N; DeLuca GC; Owens T; Esiri MM
Brain; 2005 Jan; 128(Pt 1):29-34. PubMed ID: 15548559
[TBL] [Abstract][Full Text] [Related]
2. [Spinal cord magnetic resonance imaging in multiple sclerosis: importance of determining degree of atrophy as a marker of disease course].
De Seze J; Ayachi M; Stojkovic T; Gauvrit JY; Saint Michel T; Pruvo J; Vermersch P
Rev Neurol (Paris); 2000 May; 156(5):491-6. PubMed ID: 10844368
[TBL] [Abstract][Full Text] [Related]
3. Pathogenesis of brain and spinal cord atrophy in multiple sclerosis.
Minagar A; Toledo EG; Alexander JS; Kelley RE
J Neuroimaging; 2004 Jul; 14(3 Suppl):5S-10S. PubMed ID: 15228754
[TBL] [Abstract][Full Text] [Related]
4. Measurement of spinal cord atrophy in multiple sclerosis.
Lin X; Tench CR; Evangelou N; Jaspan T; Constantinescu CS
J Neuroimaging; 2004 Jul; 14(3 Suppl):20S-26S. PubMed ID: 15228756
[TBL] [Abstract][Full Text] [Related]
5. In vivo assessment of cervical cord damage in MS patients: a longitudinal diffusion tensor MRI study.
Agosta F; Absinta M; Sormani MP; Ghezzi A; Bertolotto A; Montanari E; Comi G; Filippi M
Brain; 2007 Aug; 130(Pt 8):2211-9. PubMed ID: 17535835
[TBL] [Abstract][Full Text] [Related]
6. Spinal cord imaging in multiple sclerosis.
Tench CR; Morgan PS; Jaspan T; Auer DP; Constantinescu CS
J Neuroimaging; 2005; 15(4 Suppl):94S-102S. PubMed ID: 16385022
[TBL] [Abstract][Full Text] [Related]
7. Normalized upper cervical spinal cord atrophy in multiple sclerosis.
Song F; Huan Y; Yin H; Ge Y; Wei G; Chang Y; Zhao H
J Neuroimaging; 2008 Jul; 18(3):320-7. PubMed ID: 18318794
[TBL] [Abstract][Full Text] [Related]
8. Measurement of brain and spinal cord atrophy by magnetic resonance imaging as a tool to monitor multiple sclerosis.
Bakshi R; Dandamudi VS; Neema M; De C; Bermel RA
J Neuroimaging; 2005; 15(4 Suppl):30S-45S. PubMed ID: 16385017
[TBL] [Abstract][Full Text] [Related]
9. Neurological disability correlates with spinal cord axonal loss and reduced N-acetyl aspartate in chronic multiple sclerosis patients.
Bjartmar C; Kidd G; Mörk S; Rudick R; Trapp BD
Ann Neurol; 2000 Dec; 48(6):893-901. PubMed ID: 11117546
[TBL] [Abstract][Full Text] [Related]
10. [Magnetic resonance imaging of spinal cord lesions in 22 multiple sclerosis patients].
Kato H; Funakawa I; Hara K; Yasuda T; Terao A
Rinsho Shinkeigaku; 1994 Mar; 34(3):229-35. PubMed ID: 8200139
[TBL] [Abstract][Full Text] [Related]
11. HLA-DRB1*1501 and spinal cord magnetic resonance imaging lesions in multiple sclerosis.
Sombekke MH; Lukas C; Crusius JB; Tejedor D; Killestein J; Arteta D; Martínez A; Uitdehaag BM; Knol DL; Peña AS; Geurts JJ; De Jager PL; Barkhof F; Vrenken H; Polman CH
Arch Neurol; 2009 Dec; 66(12):1531-6. PubMed ID: 20008659
[TBL] [Abstract][Full Text] [Related]
12. Impact of disease-modifying therapies on brain and spinal cord atrophy in multiple sclerosis.
Rudick RA
J Neuroimaging; 2004 Jul; 14(3 Suppl):54S-64S. PubMed ID: 15228760
[TBL] [Abstract][Full Text] [Related]
13. [Use of magnetic resonance imaging in the diagnosis and prognosis of multiple sclerosis].
Zivadinov R; Sepcić J
Lijec Vjesn; 2006; 128(9-10):295-308. PubMed ID: 17128669
[TBL] [Abstract][Full Text] [Related]
14. [Magnetic resonance in the diagnosis and treatment of multiple sclerosis].
Rovira Cañellas A
Neurologia; 2000; 15(7):288-302. PubMed ID: 11075577
[TBL] [Abstract][Full Text] [Related]
15. Diffuse signal abnormalities in the spinal cord in multiple sclerosis: direct postmortem in situ magnetic resonance imaging correlated with in vitro high-resolution magnetic resonance imaging and histopathology.
Bergers E; Bot JC; van der Valk P; Castelijns JA; Lycklama a Nijeholt GJ; Kamphorst W; Polman CH; Blezer EL; Nicolay K; Ravid R; Barkhof F
Ann Neurol; 2002 May; 51(5):652-6. PubMed ID: 12112117
[TBL] [Abstract][Full Text] [Related]
16. Contribution of white matter lesions to gray matter atrophy in multiple sclerosis: evidence from voxel-based analysis of T1 lesions in the visual pathway.
Sepulcre J; Goñi J; Masdeu JC; Bejarano B; Vélez de Mendizábal N; Toledo JB; Villoslada P
Arch Neurol; 2009 Feb; 66(2):173-9. PubMed ID: 19204153
[TBL] [Abstract][Full Text] [Related]
17. Axonal loss in multiple sclerosis: a pathological survey of the corticospinal and sensory tracts.
DeLuca GC; Ebers GC; Esiri MM
Brain; 2004 May; 127(Pt 5):1009-18. PubMed ID: 15047586
[TBL] [Abstract][Full Text] [Related]
18. Gray matter atrophy in multiple sclerosis: a longitudinal study.
Fisher E; Lee JC; Nakamura K; Rudick RA
Ann Neurol; 2008 Sep; 64(3):255-65. PubMed ID: 18661561
[TBL] [Abstract][Full Text] [Related]
19. Brain and spinal cord atrophy in multiple sclerosis.
Simon JH
Neuroimaging Clin N Am; 2000 Nov; 10(4):753-70 ,ix. PubMed ID: 11359723
[TBL] [Abstract][Full Text] [Related]
20. Clinical-magnetic resonance imaging correlations in multiple sclerosis.
Zivadinov R; Leist TP
J Neuroimaging; 2005; 15(4 Suppl):10S-21S. PubMed ID: 16385015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
